U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07811466) titled 'Mobile Application-Based Interventions for Cannabis Use in Young Adults With First Episode Psychosis' on June 15.
Brief Summary: Psychotic disorders affect approximately 4% of Canadians and have a significant impact on individuals' well-being, their families and social networks, and healthcare systems. The development of psychosis is explained by a complex interplay of genetic and environmental factors, including the use of psychoactive substances. Frequent cannabis use can contribute to the development of psychotic disorders.
The prevalence of cannabis use disorder (CUD) in individuals with a first-episode psychosis (FEP) followe...